Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”

Documenti analoghi

• Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
  di: Van Norman, Gail A.
  Pubblicazione: (2018)
• Expanded Patient Access to Investigational New Devices: Review of Emergency and Nonemergency Expanded Use, Custom, and 3D-Printed Devices
  di: Van Norman, Gail A.
  Pubblicazione: (2018)
• Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?
  di: Holbein, M. E. Blair, et al.
  Pubblicazione: (2015)
• Expanded Access Versus Right-to-Try
  di: Walker, Scot
  Pubblicazione: (2019)
• Update to Drugs, Devices, and the FDA: How Recent Legislative Changes Have Impacted Approval of New Therapies
  di: Van Norman, Gail A.
  Pubblicazione: (2020)